MONTANUCCI, Pia
 Distribuzione geografica
Continente #
NA - Nord America 2.415
EU - Europa 1.672
AS - Asia 1.582
SA - Sud America 274
Continente sconosciuto - Info sul continente non disponibili 198
AF - Africa 34
OC - Oceania 2
Totale 6.177
Nazione #
US - Stati Uniti d'America 2.355
SG - Singapore 746
IE - Irlanda 287
IT - Italia 269
CN - Cina 240
BR - Brasile 208
HK - Hong Kong 206
RU - Federazione Russa 200
UA - Ucraina 195
FR - Francia 164
DE - Germania 145
VN - Vietnam 137
SE - Svezia 102
GB - Regno Unito 81
FI - Finlandia 79
IN - India 49
KR - Corea 40
AT - Austria 39
CA - Canada 33
BD - Bangladesh 26
TR - Turchia 24
IQ - Iraq 19
AR - Argentina 18
PL - Polonia 18
JP - Giappone 17
NL - Olanda 16
ES - Italia 15
MX - Messico 15
ZA - Sudafrica 15
CO - Colombia 14
EC - Ecuador 14
BE - Belgio 13
CZ - Repubblica Ceca 13
SA - Arabia Saudita 10
UZ - Uzbekistan 10
ID - Indonesia 9
CH - Svizzera 8
PY - Paraguay 8
MY - Malesia 6
PH - Filippine 6
PK - Pakistan 6
CL - Cile 5
ET - Etiopia 5
LB - Libano 5
GR - Grecia 4
AE - Emirati Arabi Uniti 3
EU - Europa 3
JO - Giordania 3
KE - Kenya 3
LT - Lituania 3
MA - Marocco 3
PS - Palestinian Territory 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
CR - Costa Rica 2
DK - Danimarca 2
GE - Georgia 2
IR - Iran 2
JM - Giamaica 2
LV - Lettonia 2
NO - Norvegia 2
OM - Oman 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
AG - Antigua e Barbuda 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BZ - Belize 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GP - Guadalupe 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MK - Macedonia 1
MV - Maldive 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 5.983
Città #
Singapore 542
Chandler 323
Dublin 287
San Jose 214
Hong Kong 204
Ashburn 159
San Mateo 142
Jacksonville 114
Perugia 102
Boardman 90
Santa Clara 85
Moscow 69
Ann Arbor 68
Munich 66
Medford 63
Princeton 63
Beijing 61
Altamura 56
Lauterbourg 54
Wilmington 48
Los Angeles 44
Dong Ket 42
Lawrence 41
Andover 40
Seoul 39
Ho Chi Minh City 34
Vienna 31
Des Moines 30
Redmond 30
New York 24
The Dalles 23
Hanoi 22
Piscataway 18
Helsinki 16
Houston 16
Montreal 16
Phoenix 16
Warsaw 16
Tokyo 15
Turku 15
Dallas 14
Orem 14
São Paulo 14
Norwalk 13
Saint Petersburg 13
Atlanta 12
Brussels 11
Chennai 11
Johannesburg 11
London 11
Woodbridge 11
Izmir 10
Stockholm 10
Baghdad 9
Boston 9
Manchester 9
Philadelphia 9
Rome 9
Assisi 8
Auburn Hills 8
Chicago 8
Falkenstein 8
Shanghai 8
Rio de Janeiro 7
San Francisco 7
San Paolo di Civitate 7
Tashkent 7
Amsterdam 6
Basingstoke 6
Bogotá 6
Brooklyn 6
Council Bluffs 6
Denver 6
Haiphong 6
Manfredonia 6
Milan 6
Mumbai 6
Olomouc 6
Addis Ababa 5
Ankara 5
Belo Horizonte 5
Columbus 5
Den Haag 5
Dhaka 5
Frankfurt Am Main 5
Frankfurt am Main 5
Guarulhos 5
New Delhi 5
Poplar 5
Porto Alegre 5
Quito 5
Toronto 5
Asunción 4
Brno 4
Buffalo 4
Da Nang 4
Falls Church 4
Fremont 4
Guayaquil 4
Jeddah 4
Totale 3.774
Nome #
Effects of streptozotocin on beta-cell precursor activatio in human islet derived cell monolayers 155
A comparison of lysosomal enzymes expression levels in peripheral blood of mild- and severe-Alzheimer’s disease and MCI patients: Implications for regenerative medicine approaches 141
Microencapsulated G3C hybridoma cell graft delays the onset of spontaneous diabetes in NOD mice by an expansion of Gitr+ Treg cells 140
Microencapsulation of cells and molecular therapy of type 1 diabetes mellitus: The actual state and future perspectives between promise and progress 134
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 133
MICROENCAPSULATED ISLET ALLOGRAFTS INTO NONIMMUNOSUPPRESSED PATIENTS WITH TYPE 1 DIABETES (TIDM) 131
Human Umbilical Cord Wharton Jelly-Derived Adult Mesenchymal Stem Cells, in Biohybrid Scaffolds, for Experimental Skin Regeneration 126
In vivo HSV-1 T0Ahex gene transfer strategy for Tay-Sachs disease provides a wide distribution of B-Hexosaminidase A and restores the GM2 ganglioside metabolims in the brain animal model 125
Absence of metabolic cross-correction in Tay-Sachs cells: implication in gene therapy 123
Long-term cultured neonatal porcine islet cell monolayers: a potential tissue source for transplant in diabetes. 120
PRECURSORI BETA-CELLULARI IN COLTURE DI INSULE PANCREATICHE UMANE SOTTOPOSTE A STRESS IN VITRO 119
NMR analysis of non hydrolyzed samples of sodium alginate 119
Human Umbilical Cord Wharton Jelly-derived Adult Mesenchymal Stem Cells (hUCMS) in Microcapsules (CpS): A Novel Biohybrid System for Immunomodulation in T1D 117
Effects Of Streptozotocin On Beta-Cell Precursor Activation In Human Islet Derived Cell Monolayers. 113
Effect of all trans retinoic acid on lysosomal alpha-D: -mannosidase activity in Hl-60 cell: correlation with Hl-60 cells differentiation 112
Alpha and Beta subunits of b-N-acethyl-hexosaminidase are differently regulated during the mammalian brain development: implication for Tay-Sachs disease therapy 112
EFFECTS OF POLI-L-LYSINE AND COLLAGEN ON FH-B-TPN CELL DIFFERENTIATION INTO ENDOCRINE CELL PHENOTYPE 111
Immunomodulatory effects of human umbelical cord Wharton jelly-derived mesenchymal stem cells (hUCMS) on circulating T-cell subsets in patients with Sjogren's syndrome 107
A8. 6 A novel therapeutic approach in systemic rheumatic autoimmune disorders: encapsulated human umbilical cord wharton jelly-derived mesenchymal stem cells 107
Design of a nanocomposite substrate inducing adult stem cell assembly and progression toward an Epiblast-like or Primitive Endoderm-like phenotype via mechanotransduction 107
Co-microencapsulation of human umbilical cord-derived mesenchymal stem and pancreatic islet-derived insulin producing cells in experimental type 1 diabetes 107
EFFECTS OF STRPTOZOTOCIN ON IN VITRO LONG TERM CULTURED HUMAN ISLETS CELLS MONOLAYERS 106
Brain-directed gene transfer therapy for Tay-Sachs disease gives rice a wider distribution of the B-Hexosaminidase A 102
ENGINEERED ALGINATE MICROCAPSULES FOR MOLECULAR THERAPY TROUGH BIOLOGIC SECRETING CELLS 100
Neonatal pig liver-derived progenitors for insulin-producing cells: an in vitro study 99
Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. 98
Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts : four cases 97
Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model 96
Insights in Behavior of Variably Formulated Alginate-Based Microcapsules for Cell Transplantation 96
Reversal of Hyperglycemia by Microencapsulated Human Umbilical Cord Wharton Jelly-Derived Adult Mesenchymal Stem Cells (hUCMS) Graft (TX) in Spontaneously Nonobese Diabetic (NOD) Mice 96
Study of the maternal-foetal interface in women with obesity and gestational diabetes as a potential mirror of foetal programming 96
A9.18 Potential Therapeutic Application of Human Umbilical Cord wharton Jelly Derived Mesenchymal Stem Cells in Primary Sjogren's Syndrome 95
Prevention of diabetes in NOD mice by increasing GITR positive Treg cells by low doses of anti-GITR antibody 92
Microencapsulated Umbilical Cord Wharton Jelly-Derived Human Mesenchymal Stem Cells for the Cell Therapy of Type 1 Diabetes Mellitus (T1d): Applications and Limits 92
Evidence for altered late endosomal-lysosomal compartment in Sandhoff fibroblasts 91
Direct brain gene transfer strategy for Tay-Sachs disease 91
Stem Cells for the Cell and Molecular Therapy of Type 1 Diabetes Mellitus (T1D) between Lights and Shadows 90
Remission of hyperglycemia in spontaneously diabetic NOD mice upon transplant of microencapsulated human umbilical cord Wharton jelly-derived mesenchymal stem cells (hUCMS) 89
Utilization of a Commercial 3D Printer for the Construction of a Bio-Hybrid Device Based on Bioink and Adult Human Mesenchymal Cells 87
Nano-engineered PLLA based biomaterial drives stem cell responses 86
Functional Profiles of Human Umbilical Cord-Derived Adult Mesenchymal Stem Cells in Obese/Diabetic Versus Healthy Women 86
Surface Hydrophilicity of Poly(l-Lactide) Acid Polymer Film Changes the Human Adult Adipose Stem Cell Architecture 86
Emerging of a new CD3+CD31HCD184+ tang cell phenothype in Sjögren's syndrome induced by microencapsulated human umbilical cord matrix-derived multipotent stromal cells 84
Restoration of t cell substes of patients with type 1 diabetes mellitus by microencapsulated human umbilical cord wharton jelly-derived mesenchymal stem cells: An in vitro study 83
Microencapsulated Wharton Jelly-derived adult mesenchymal stem cells as a potential new therapeutic tool for patients with COVID-19 disease: an in vitro study 83
NMR analysis of sodium alginate 80
Xenotransplantation of microencapsulated human wharton jelly-derived adult mesenchymal stem cells (HUCMS) into overtly diabetic NOD mice 80
Directed hexa gene transfer therapy for Tay-Sachs disease provides a wide brain distribution of the B-Hexosaminidase a and restores the GM2 ganglioside metabolism 77
The functional performance of microencapsulated human pancreatic islet-derived precursor cells. 77
Immunomodulatory effects of human umbilical cord wharton jelly-derived mesenchymal stem cells (HUCMS) on circulating T-cell subsets in patients with sjögren’s syndrome 77
In vivo gene transfer strategy for Tay-Sachs disease restores the GM2 ganglioside in the brain of the animal model 77
Treatment of diabetes mellitus with microencapsulated fetal human liver (FH-B-TPN) engineered cells 76
Clinical grade sodium alginate for microencapsulation of myofibroblasts isolated from wharton jelly for prevention and treatment of autoimmune and inflammatory diseases 76
Molecular Characterization of Postpartum Umbilical Cord Wharton Jelly-derived Human Adult Mesenchymal Stem Cells (hUCMS) in Healthy vs. Obese/Diabetic Mothers 74
THERAPEUTIC APPLICATION OF HUMAN UMBILICAL CORD WHARTON JELLY-DERIVED MESENCHYMAL STEM CELLS (HUCMS) IN SYSTEMIC LUPUS ERYTHEMATOSUS: PITFALLS AND PERSPECTIVES 71
New simple and rapid method for purification of mesenchymal stem cells from the human umbilical cord 69
In Vitro Cultured Human Islet Cell Monolayers : Stemness Markers and Insulin Recovery upon Streptozotocin exposure. 68
Microencapsulation of Islets for the Treatment of Type 1 Diabetes Mellitus (T1D). 67
Umbilical cord mesenchymal stem cells for the treatment of autoimmune diseases: Beware of cell-to-cell contact 67
Neonatal Pig Liver – Derived Undifferentiated Cells: A Potential New Source For Insulin Production 66
Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus. 66
Islet transplantation versus stem cells for the cell therapy of type 1 diabetes mellitus 61
Stem cells for pancreatic β-cell replacement in diabetes mellitus 61
In vitro immunomodulatory effects of microencapsulated umbilical cord Wharton jelly-derived mesenchymal stem cells in primary Sjögren's syndrome. 56
ULTRAPURIFIED ALGINATE-BASED MICROCAPSULES FOR IMMUNOPROTECTION OF HUMAN ISLET ALLOGRAFTS IN TYPE 1 DIABETES MELLITUS 51
Totale 6.177
Categoria #
all - tutte 28.059
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.059


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022410 0 0 41 19 15 4 3 168 4 24 51 81
2022/20231.039 68 185 14 83 79 108 13 43 371 4 47 24
2023/2024413 33 38 23 8 2 4 134 10 25 12 61 63
2024/2025905 11 91 35 73 113 35 20 58 170 63 159 77
2025/20262.026 147 99 100 270 328 192 340 99 216 171 47 17
2026/2027140 37 56 47 0 0 0 0 0 0 0 0 0
Totale 6.177